Evaluating the feasibility of a real world pharmacovigilance study (OPTIMISE:MS)

  • Ruth Dobson*
  • , Matthew Craner
  • , Ed Waddingham
  • , Aleisha Miller
  • , Jayant Pindoria
  • , Ana Cavey
  • , Camilla Blain
  • , Luca G De
  • , Nikos Evangelou
  • , Helen Ford
  • , Paul Gallagher
  • , Katila George
  • , Ramos Dias R Geraldes
  • , Paula Harman
  • , Jeremy Hobart
  • , Tanya King
  • , Ruth Linighan
  • , Niall MacDougall
  • , Monica Marta
  • , Stephanie Mitchell
  • Richard Nicholas, David Rog, Antonio Scalfari, Neil Scolding, Stewart Webb, Sarah White, Judith Wilton, Carolyn Young, Paul M. Matthews
*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

20 Downloads (Pure)
Original languageEnglish
Number of pages0
JournalMultiple Sclerosis and Related Disorders
Volume63
Issue number0
Early online date27 May 2022
DOIs
Publication statusPublished - Jul 2022

Cite this